Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sonia Vallet, Martin Pecherstorfer & Klaus Podar. (2017) Adoptive cell therapy in multiple Myeloma. Expert Opinion on Biological Therapy 17:12, pages 1511-1522.
Read now
Read now
Alpana Sharma, Rehan Khan, Suhasini Joshi, Lalit Kumar & Manoj Sharma. (2010) Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma. Leukemia & Lymphoma 51:5, pages 920-927.
Read now
Read now
Articles from other publishers (28)
Abid Naeem, Pengyi Hu, Ming Yang, Jing Zhang, Yali Liu, Weifeng Zhu & Qin Zheng. (2022) Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules 27:23, pages 8367.
Crossref
Crossref
Hongru Zhu, Lidong Guo, Dan Yu & Xiaowei Du. (2022) New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines. Frontiers in Microbiology 13.
Crossref
Crossref
Qing Yuan, Kunwei Niu, Lijun Sun, Bo Zhao, Xiao-yu Wang & Bing Wang. (2022) BAP31 affects macrophage polarization through regulating helper T cells activation. Journal of Molecular Histology 53:5, pages 843-855.
Crossref
Crossref
Huihai Yang, Lulu Wang & Jing Zhang. (2022) Leukocyte modulation by natural products from herbal medicines and potential as cancer immunotherapy. Journal of Leukocyte Biology 112:1, pages 185-200.
Crossref
Crossref
Huihai Yang, Jing Zhang & Jiawei Ling. (2022) The Modulatory Effects and Targets Prediction of Herbal Medicines or Phytochemicals on Cancer Immunosurveillance. The American Journal of Chinese Medicine 50:06, pages 1401-1422.
Crossref
Crossref
Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Ramón García-Sanz, María-Victoria Mateos, Mercedes Garayoa & Teresa Paíno. (2021) Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers 13:6, pages 1353.
Crossref
Crossref
Joselle Cook, Aldo A. Acosta-Medina, Kah Whye Peng, Martha Lacy & Stephen Russell. (2021) Oncolytic virotherapy – Forging its place in the immunomodulatory paradigm for Multiple Myeloma. Cancer Treatment and Research Communications 29, pages 100473.
Crossref
Crossref
Patrizia Leone, Antonio Giovanni Solimando, Eleonora Malerba, Rossella Fasano, Alessio Buonavoglia, Fabrizio Pappagallo, Valli De Re, Antonella Argentiero, Nicola Silvestris, Angelo Vacca & Vito Racanelli. (2020) Actors on the Scene: Immune Cells in the Myeloma Niche. Frontiers in Oncology 10.
Crossref
Crossref
Yeshu Wang, Qunfang Zhang, Yuchao Chen, Chun-Ling Liang, Huazhen Liu, Feifei Qiu & Zhenhua Dai. (2020) Antitumor effects of immunity-enhancing traditional Chinese medicine. Biomedicine & Pharmacotherapy 121, pages 109570.
Crossref
Crossref
Fabienne Lucas, Michael Pennell, Ying Huang, Don M. Benson, Yvonne A. Efebera, Maria Chaudhry, Tiffany Hughes, Jennifer A. Woyach, John C. Byrd, Suohui Zhang, Desiree Jones, Xiangnan Guan, Christin E. Burd & Ashley E. Rosko. (2020) T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma. Biology of Blood and Marrow Transplantation 26:1, pages 7-15.
Crossref
Crossref
Barry Paul, Shuqi Kang, Zhihong Zheng & Yubin Kang. (2018) The challenges of checkpoint inhibition in the treatment of multiple myeloma. Cellular Immunology 334, pages 87-98.
Crossref
Crossref
Camille Guillerey, Kyohei Nakamura, Slavica Vuckovic, Geoffrey R. Hill & Mark J. Smyth. (2016) Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies. Cellular and Molecular Life Sciences 73:8, pages 1569-1589.
Crossref
Crossref
Sabrina Fichtner, Dirk Hose, Melanie Engelhardt, Tobias Meißner, Brigitte Neuber, Fatime Krasniqi, Marc Raab, Stefan Schönland, Anthony D. Ho, Hartmut Goldschmidt & Michael Hundemer. (2015) Association of Antigen-Specific T-cell Responses with Antigen Expression and Immunoparalysis in Multiple Myeloma. Clinical Cancer Research 21:7, pages 1712-1721.
Crossref
Crossref
M. Binsfeld, K. Fostier, J. Muller, F. Baron, R. Schots, Y. Beguin, R. Heusschen & J. Caers. (2014) Cellular immunotherapy in multiple myeloma: Lessons from preclinical models. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 392-404.
Crossref
Crossref
Sarah M. Tete, Marc Bijl, Surinder S. Sahota & Nicolaas A. Bos. (2014) Immune Defects in the Risk of Infection and Response to Vaccination in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Frontiers in Immunology 5.
Crossref
Crossref
D Atanackovic, T Luetkens & N Kröger. (2013) Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma. Leukemia 28:5, pages 993-1000.
Crossref
Crossref
Yesim Gökmen-Polar, Mangesh A. Thorat, Payal Sojitra, Rashmil Saxena & Sunil Badve. (2013) FOXP3 expression and nodal metastasis of breast cancer. Cellular Oncology 36:5, pages 405-409.
Crossref
Crossref
Jessica M. S. Jutzy, Salma Khan, Malyn May Asuncion-Valenzuela, Terry-Ann M. Milford, Kimberly J. Payne & Nathan R. Wall. (2012) Tumor-Released Survivin Induces a Type-2 T Cell Response and Decreases Cytotoxic T Cell Function, in Vitro. Cancer Microenvironment 6:1, pages 57-68.
Crossref
Crossref
Giorgio Fedele, Marco Di Girolamo, Umberto Recine, Raffaella Palazzo, Francesca Urbani, Alberto L. Horenstein, Fabio Malavasi & Clara Maria Ausiello. (2013)
CD38 Ligation in Peripheral Blood Mononuclear Cells of Myeloma Patients Induces Release of Protumorigenic IL-6 and Impaired Secretion of IFN
γ
Cytokines and Proliferation
. Mediators of Inflammation 2013, pages 1-7.
Crossref
Crossref
Constantin A Dasanu. (2011) Immune alterations in untreated and treated multiple myeloma. Journal of Oncology Pharmacy Practice 18:2, pages 257-263.
Crossref
Crossref
Lidia Karabon, Edyta Pawlak-Adamska, Anna Tomkiewicz, Anna Jedynak, Marek Kielbinski, Dariusz Woszczyk, Stanisław Potoczek, Anna Jonkisz, Kazimierz Kuliczkowski & Irena Frydecka. (2011) Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population. Pathology & Oncology Research 18:2, pages 219-226.
Crossref
Crossref
Maurizio Chiriva‐Internati, Yuefei Yu, Leonardo Mirandola, Nicholas D'Cunha, Fred Hardwicke, Martin J. Cannon, Everardo Cobos & W. Martin Kast. (2011) Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. The Prostate 72:1, pages 12-23.
Crossref
Crossref
Monia Tangour, Ines Chelly, Slim Haouet, Moncef Zitouna & Nidhameddine Kchir. (2011) Multiple myeloma and cutaneous anaplastic large T-cell lymphoma in the same patient: Is there a causal relation?. Journal of Cutaneous Pathology 38:3, pages 298-300.
Crossref
Crossref
M E Christine Lutsiak, Glen S Kwon & John Samuel. (2006) Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. Journal of Pharmacy and Pharmacology 58:6, pages 739-747.
Crossref
Crossref
M. Har-Noy, M. Zeira, L. Weiss, E. Fingerut, R. Or & S. Slavin. (2009) Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma. Leukemia Research 33:4, pages 525-538.
Crossref
Crossref
Michael R. Shurin, Galina V. Shurin, Anna Lokshin, Zoya R. Yurkovetsky, Dmitry W. Gutkin, Gurkamal Chatta, Hua Zhong, Baohui Han & Robert L. Ferris. (2006) Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?. Cancer and Metastasis Reviews 25:3, pages 333-356.
Crossref
Crossref
MUAMMER SEYHAN, BAŞAK KANDI COŞKUN, HÜLYA SAĞLAM, HAMDI ÖZCAN & YELDA KARINCAOĞLU. (2006) Psoriasis in childhood and adolescence: evaluation of demographic and clinical features. Pediatrics International 48:6, pages 525-530.
Crossref
Crossref
Ingolf Molle, Rudi Steffensen, Steffen Thiel & Niels A. Peterslund. (2006) Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. European Journal of Haematology 77:1, pages 19-26.
Crossref
Crossref